VR Adviser, LLC
- SEC CIK
- 0001615982
- Latest filing
- Aug 14, 2026
TVTX holding history
Travere Therapeutics, Inc. in every 13F filed by VR Adviser, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TVTX overviewAll 13F holders of TVTXFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −2,623,677−100.0% | Sold out | Holders |
| Q3 2023 | 2,623,677 | $23.5M | 2.5% | +2,623,677 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −1,711,102−100.0% | Sold out | Holders |
| Q2 2022 | 1,711,102 | $41.5M | 8.2% | −283,895−14.2% | Reduced | Holders |
| Q1 2022 | 1,994,997 | $51.4M | 8.3% | 00.0% | Unchanged | Holders |
| Q4 2021 | 1,994,997 | $61.9M | 8.5% | +262,587+15.2% | Added | Holders |
| Q3 2021 | 1,732,410 | $42.0M | 5.4% | +1,732,410 | New | Holders |